Nice viewpoint on our recent PNAS paper by DeSpenza et al. - concurrent mutational impact on CSF dynamics and intrinsic brain connectivity. Implications for how we counsel neurosurgical patients. ⁦MGH Neurosurgery⁩ ⁦Duke Neurosurgery⁩ pnas.org/doi/abs/10.107…

REGISTRATION IS OPEN for the Fukushima Memorial Symposium, Nov. 16, 2024, on the Duke University campus. neurosurgery.duke.edu/fukushima-memo…

Hard to top free ice cream between cases. Had fun showing one of our current Sub-Is, Sera, some perks of Duke Neurosurgery!

Thinking about residency? Come to Duke’s online First Look event August 28, 7-8:30pm ET & talk to program leaders, faculty, & residents. All med students welcome. Register here: duke.is/Duke-First-Loo… #MedTwitter #MedEd #residency

A new study finds a genetic variant among people who experience a rare recovery from #ALS Duke Health Duke University School of Medicine Duke Neurology corporate.dukehealth.org/news/study-fin…

The U.S. FDA has just approved #vorasidenib for the treatment of #glioma. Here's a backgrounder on the drug's development and the results of the clinical trials. neurosurgery.duke.edu/news/new-thera… Duke University School of Medicine Duke Health Preston Robert Tisch Brain Tumor Center @ Duke Katy Peters

Vorasidenib Secures FDA Approval in IDH-Mutant Diffuse Glioma targetedonc.com/view/vorasiden… via @targetedonc Katy Peters

Duke research leads to a new brain cancer treatment getting FDA approval axios.com/local/raleigh/…

Registration is open for the Fukushima Memorial Symposium at Duke Neurosurgery, honoring the late Takanori Fukushima. neurosurgery.duke.edu/fukushima-memo…

It was a big day for #MetsGetsAwareness. Congresswoman Valerie Foushee Duke Spine Amanda Van Swearingen, PhD Carey Anders Preston Robert Tisch Brain Tumor Center @ Duke Duke Health Duke Cancer Duke University School of Medicine Duke University Mary E. Klotman, MD Peter Fecci American Brain Tumor Association SNO Read more: neurosurgery.duke.edu/news/congressw…

Today, Amanda Jenson, MD, has joined the faculty of the Duke Department of Neurosurgery in the Pediatric Neurosurgery Division. Welcome, Dr. Jenson! neurosurgery.duke.edu/news/amanda-je…

The FDA approved #vorasidenib for adult and pediatric patients 12 and older with Grade 2 #astrocytoma or #oligodendroglioma. It’s the culmination of 16 years of research and clinical trials involving Duke researchers.Katy Peters Preston Robert Tisch Brain Tumor Center @ Duke wral.com/story/fda-give…

During #NeurosurgeryAwarenessMonth, we’re excited to congratulate @DukeNeurosurg and Johns Hopkins Neurosurgery for their work on the newly FDA-approved brain tumor drug, marking a significant step forward in the fight against #braintumors and showcasing that #neurosurgery is more than just

ICYMI: Vorasidenib Secures #FDA Approval in IDH-Mutant Diffuse Glioma! Katy Peters Preston Robert Tisch Brain Tumor Center @ Duke Duke Neurology Duke Neurosurgery targetedonc.com/view/vorasiden…

Exclusive: Duke spinout launches in hopes of prevailing with brain cancer bispecific where Amgen, Roche did not - endpts.com/exclusive-duke…

Welcome, Dr. Fatemi!

Elderly patient involved in MVA. Underwent a perc S1 sacroiliac fixation by Dr. Malcolm R. DeBaun, Duke Orthopaedics. Due to  lumbopelvic dissociation,  underwent a robotic-assisted percutaneous L4-pelvis fixation with our team Duke Spine . 6 months postop, patient can walk unassisted.

It was great hosting Dr. Simon Balogun from Nigeria and Dr. Daouda Sissoko from Mali this week. We first met in South Africa @WFNS. I’ll rep Egypt to complete the African theme:) Duke Neurosurgery

We have a full day of exciting science today at the annual Duke Center for Brain and Spine Metastasis Research Retreat 🧪🔬 #MetsGetsAwareness #CancerResearch

On Sept 16 Duke's david hasan and Dr. Seth Cohen will participate in a forum re. the Israel-Palestine Conflict. Hasan is Palestinian, Cohen is Jewish, but both had the impulse to help, traveling to Gaza and Israel to provide care. today.duke.edu/2024/09/amid-c…